Pierre-Simon Bellaye is an expert in Pulmonology at Centre Georges François Leclerc (France). Pierre-Simon Bellaye has authored 100 publications, the most recent in 2026. SLR score: 352 (community average: 125). How the SLR is computed.

LeadR Profile

Pierre-Simon Bellaye Centre Georges François Leclerc France
352 ScienceLeadR Reputation 352
Network Map

Pulmonology

Subspecialties: Oncology - Biochemistry - Pharmacy

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026

Source: PubMed

INSERM

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 100

Citations

Citations: 2 263 1st author: 19 Last author: 9 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Ultrasensitive detection of lung inflammation in male mice using immuno-magnetic particle imaging.
PMID 42642371 — lung, biological science disciplines, antibodies, magnetic particle imaging
Nat Commun20261
Unexpected Reactivity of 1,3,4-Thiadiazole-N-oxides with Strained Alkynes Enables Enhanced Antibody Loading.
PMID 42619102 — thiadiazoles, alkynes
J Am Chem Soc20260
External Beam Radiotherapy Primes PDL1-Targeted Radionuclide Therapy in Preclinical Colorectal Cancer Model.
PMID 42362068 — radiotherapy, cells, neoplasms, colon, therapeutics, colorectal neoplasms, spleen
Int J Radiat Oncol Biol Phys20260
IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.
PMID 42331382 — cells, killer cells, natural, macrophages, neoplasms, immunotherapy, immunity, vascular endothelial growth factor receptor-2, therapeutics, colorectal neoplasms, interleukin-10, angiogenesis
J Immunother Cancer20261
SPECT/NIR Fluorescence Bimodal Use of Aza-BODIPY Probe Coupled with Cetuximab for Detection of Cancer: Proof of Concept on a Preclinical Head and Neck Squamous Cell Carcinoma Model.
PMID 42012405 — cells, cetuximab, carcinoma, squamous cell, neoplasms, squamous cell carcinoma of head and neck, tomography, emission-computed, single-photon
J Med Chem20260

LeadR Networks

Main global connection map